Psychedelics Reduce Anxiety, Depression in Patients, Study Finds – Baltimore Sun

“Researchers at the Johns Hopkins University School of Medicine have found that a psychedelic drug can significantly reduce anxiety, depression and other emotional distress in cancer patients.

The patients experienced almost immediate relief, which lasted for months, after taking psilocybin, the active hallucinogenic ingredient in “magic mushrooms,” the researchers reported. A separate study by researchers at NYU Langone Medical Center found the same effect.”

Read the full Baltimore Sun article by Andrea K. McDaniels here